Immunic Inc (IMUX) — Cash Flow-to-Debt Ratio

Latest as of December 2025: -0.63x

Immunic Inc (IMUX) has a Cash Flow-to-Debt Ratio of -0.63x as of December 2025, meaning its operating cash flow of $-19.28 Million could theoretically repay -1% of its total liabilities ($30.73 Million) in one year. See IMUX working capital ratio to evaluate short-term liquidity relative to the company's equity base.

CF-to-Debt Ratio

-0.63x
Operating CF / Total Liabilities

Operating Cash Flow

$-19.28 Million
USD

Total Liabilities

$30.73 Million
USD

Data as of

Dec 2025
Most recent filing

Immunic Inc Cash Flow-to-Debt Ratio (2011–2025)

Historical debt coverage capacity for Immunic Inc across 15 annual periods. Also explore IMUX net assets growth trend to track the company's year-over-year net asset growth rate.

Annual Cash Flow-to-Debt Ratio for Immunic Inc (2011–2025)

Year-by-year debt coverage analysis for Immunic Inc. For market capitalisation and broader financial context, see how much is Immunic Inc worth.

Year CF-to-Debt Ratio Operating CF (USD) Total Liabilities YoY Change
2025 -2.79x $-85.81 Million $30.73 Million ▲ +26.1%
2024 -3.78x $-84.77 Million $22.44 Million ▼ -35.3%
2023 -2.79x $-70.83 Million $25.37 Million ▲ +39.7%
2022 -4.63x $-65.14 Million $14.07 Million ▲ +33.3%
2021 -6.94x $-83.23 Million $11.98 Million ▼ -36.7%
2020 -5.08x $-46.12 Million $9.08 Million ▼ -35.2%
2019 -3.76x $-28.55 Million $7.59 Million ▲ +77.8%
2018 -16.92x $-43.16 Million $2.55 Million ▼ -333.1%
2017 -3.91x $-40.40 Million $10.34 Million ▲ +39.1%
2016 -6.41x $-35.77 Million $5.58 Million ▲ +13.3%
2015 -7.39x $-49.95 Million $6.76 Million ▼ -90.5%
2014 -3.88x $-40.83 Million $10.52 Million ▲ +30.0%
2013 -5.54x $-28.65 Million $5.17 Million ▼ -1577.2%
2012 -0.33x $-9.24 Million $27.96 Million ▼ -139.9%
2011 -0.14x $-7.83 Million $56.84 Million
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.